| Home > Articles > Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO) > Access to Fulltext |
|
|
|||||||
| version 1 |
| ||||||